schizophrenia

ai-in-mental-health-diagnosis-and-treatment

Apr 23, 2025

Exploring the Impact of AI in Mental Health: How it is Going to Revolutionize Diagnosis and Treatment for a Better Tomorrow?

pharma-news-for-amgen-novo-nordisk-boehringer

Jan 21, 2025

FDA Approves LUMAKRAS with VECTIBIX for KRAS G12C-Mutated Colorectal Cancer; PYC Receives FDA Rare Pediatric Disease Designation for VP-001; Novo Nordisk Links High-Dose WEGOVY to Increased Weight Loss; FDA Rejects Atara’s EBVALLO Due to Manufacturing Issues; Boehringer Faces Phase III Schizophrenia Fail and Legal Challenges

Pharma-news-for-autolus-unicycive-abbvie

Nov 12, 2024

AUCATZYL Approved for R/R B-ALL; FDA Accepts NDA for Unicycive’s Oxylanthanum Carbonate; AstraZeneca and Amgen Report Positive Results in Chronic Rhinosinusitis; Nipocalimab Granted Breakthrough Designation for Sjögren’s Disease; AbbVie’s Schizophrenia Drug Fails Phase Studies

schizophrenia-treatment-and-management-assessment

Oct 18, 2024

Breaking Boundaries: Innovations and Updates in Schizophrenia Treatment

Schizophrenia vs Bipolar disorder Biomarkers to the rescue

Oct 18, 2024

Schizophrenia vs Bipolar disorder: Biomarkers to the rescue

Oct 18, 2024

How are Antipsychotics Transforming the Schizophrenia Treatment Space?

Pharma-news-for-bms-intrabio-pfizer

Oct 01, 2024

IntraBio’s AQNEURSA Niemann-Pick Disease Approval; FDA Approves Novel Schizophrenia Drug After 35 Years; Selpercatinib Gets FDA Nod for RET-Mutated MTC; DUPIXENT Receives First-Ever COPD Approval; Pfizer Withdraws OXBRYTA for Sickle Cell Disease from Global Market

5-schizophrenia-drugs-challenging-bms-karxt

Sep 30, 2024

5 Upcoming Schizophrenia Drugs Competitors for Newly Approved BMS’ KarXT (COBENFY)

evenamide-phase-ii-iii-trial-result

Apr 15, 2024

Evenamide (NW-3509): Advancing Solutions for Treatment-Resistant Schizophrenia

brilaroxazine-for-schizophrenia

Apr 12, 2024

Hope on the Horizon: Brilaroxazine’s Promise for Schizophrenia Patients

Toll-like Receptors Agonist
TLR 7 and 8 Agonist
Gene Therapies Whitepaper
Toll-like Receptors Agonist
TLR 7 and 8 Agonist
Gene Therapies Whitepaper

Newsletter/Whitepaper